Welcome! Please Log In
Search
Analyst Notes by Industry
Advertising Agencies …Aerospace & Defense …Agricultural Inputs …Airlines …Airports & Air Services …Aluminum …Apparel Manufacturing …Apparel Stores …Asset Management …Auto & Truck Dealerships …Auto Manufacturers …Auto Parts …Banks - Global …Banks - Regional - Asia …Banks - Regional - …Banks - Regional - Latin …Banks - Regional - US …Beverages - Brewers …Beverages - Soft Drinks …Beverages - Wineries & …Biotechnology …Broadcasting - TV …Building Materials …Business Equipment …Business Services …Capital Markets …Chemicals …Coal …Communication Equipment …Computer Distribution …Computer Systems …Confectioners …Consumer Electronics …Copper …Credit Services …Data Storage …Department Stores …Diagnostics & Research …Discount Stores …Diversified Industrials …Drug Manufacturers - …Drug Manufacturers - …Education & Training …Electronic Components …Electronic Gaming & …Electronics Distribution …Engineering & …Farm & Construction …Farm Products …Financial Exchanges …Food Distribution …Footwear & Accessories …Gambling …Gold …Grocery Stores …Health Care Plans …Health Information …Home Furnishings & …Home Improvement Stores …Household & Personal …Industrial Distribution …Industrial Metals & …Information Technology …Infrastructure …Insurance - Diversified …Insurance - Life …Insurance - Property & …Insurance - Reinsurance …Insurance Brokers …Integrated Shipping & …Internet Content & …Leisure …Lodging …Long-Term Care …Lumber & Wood Production …Luxury Goods …Marketing Services …Media - Diversified …Medical Care …Medical Devices …Medical Distribution …Medical Instruments & …Metal Fabrication …Oil & Gas Drilling …Oil & Gas E&P …Oil & Gas Equipment & …Oil & Gas Integrated …Oil & Gas Midstream …Oil & Gas Refining & …Packaged Foods …Packaging & Containers …Paper & Paper Products …Pay TV …Personal Services …Publishing …Railroads …Real Estate - General …Real Estate Services …Recreational Vehicles …REIT - Diversified …REIT - Healthcare …REIT - Hotel & Motel …REIT - Industrial …REIT - Office …REIT - Residential …REIT - Retail …Residential Construction …Resorts & Casinos …Restaurants …Savings & Cooperative …Scientific & Technical …Security & Protection …Semiconductor Equipment …Semiconductors …Shipping & Ports …Software - Application …Software - …Solar …Specialty Chemicals …Specialty Retail …Staffing & Outsourcing …Steel …Telecom Services …Tobacco …Trucking …Utilities - Diversified …Utilities - Independent …Utilities - Regulated …Utilities - Regulated …Utilities - Regulated …Waste Management …
Stock Analyst Notes (Biotechnology )
We publish Analyst Notes each weekday to keep you up-to-date on the stocks we cover. To get Analyst Notes every morning through email, sign up here.
 All Stock Analyst Notes Click on column headings to sort list.
1– 31 of 31   First 50   All (may be slower to load)
Sort alphabetically by company : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Date Analyst Note Full Analyst Report
05-18-15 Kite Reports 1Q Results; Upcoming Investor Day and Pivotal Trial Initiation Are Key Catalysts Kite Pharma Inc
05-14-15 Dropping Coverage of QLT QLT Inc
05-14-15 Dropping Coverage of QLT QLT Inc
05-14-15 Strong ASCO Data Supports Our Above-Consensus IO Sales Projections; Merck Looks Most Undervalued Roche Holding AG
05-14-15 Strong ASCO Data Supports Our Above-Consensus IO Sales Projections; Merck Looks Most Undervalued Roche Holding AG
05-14-15 SIRFLOX Secondary Endpoint Data Supports Use in Late-Stage Liver Cancer for Sirtex SIR-Spheres Sirtex Medical Ltd
05-13-15 BioMarin's 1Q Results Supported by Strong Vimizim Launch; Drisapersen Approval Could Come Late 2015 Biomarin Pharmaceutical Inc
05-08-15 Alnylam's Broad Pipeline Continues to Advance in 1Q; Maintaining Fair Value Estimate Alnylam Pharmaceuticals Inc
05-08-15 Jazz’s First-Quarter Results Led by Solid Xyrem Performance; Overdependence Still a Concern Jazz Pharmaceuticals PLC
05-08-15 Disappointing Initial Afrezza Launch Trends Result in Lower Sales Estimates and FVE for MannKind MannKind Corp
05-07-15 Lowering Our Grifols Fair Value Estimate on Weaker FX Tailwind and Pressure on 2015 Plasma Sales Grifols SA
05-07-15 Lowering Our Grifols Fair Value Estimate on Weaker FX Tailwind and Pressure on 2015 Plasma Sales Grifols SA
05-07-15 Regeneron Reports Strong 1Q as Eylea Growth Benefits from DME Indication; Increasing FVE Regeneron Pharmaceuticals Inc
05-07-15 Vanda's Hetlioz Launch Continues to Progress; Maintaining Fair Value Estimate Vanda Pharmaceuticals Inc
05-06-15 Synageva Deal Strengthens Alexion’s Rare Disease Pipeline But at Too High a Price; Lowering FVE Alexion Pharmaceuticals Inc
05-05-15 Isis Obtains Attractive Deal Terms and Partner for Antithrombotic Drug; Increasing FVE Modestly ISIS Pharmaceuticals Inc
05-01-15 Exelixis 1Q Results as Expected; Key Phase III Results Expected Mid-Year Exelixis Inc
05-01-15 QLT Holds Costs Steady QLT Inc
05-01-15 QLT Holds Costs Steady QLT Inc
05-01-15 Seattle Genetics Reports In-Line 1Q Results; Maintaining Fair Value Estimate Seattle Genetics Inc
04-30-15 Celgene 1Q Results In-Line, Firm Secures Even More Partnerships; Maintaining Our Fair Value Estimate Celgene Corp
04-30-15 Gilead Sees Strong 1Q, Raises Guidance; High Cash Levels Mean Acquisitions Will Be Tough to Avoid Gilead Sciences Inc
04-30-15 Incyte Reports Solid 1Q as Attractive Pipeline Continues to Progress Incyte Corp
04-30-15 Lexicon's 1Q In-Line, Remains on Track to Generate Late-Stage Pipeline Data Starting in 3Q Lexicon Pharmaceuticals Inc
04-30-15 Novo's 1Q Results and Recent Tresiba Filing Put It on Track to Meet Our Expectations Novo Nordisk A/S
04-30-15 Novo's 1Q Results and Recent Tresiba Filing Put It on Track to Meet Our Expectations Novo Nordisk A/S
04-30-15 Shire Reports Solid 1Q on Strong Vyvanse sales; Increasing FVE Modestly Shire PLC
04-30-15 Shire Reports Solid 1Q on Strong Vyvanse sales; Increasing FVE Modestly Shire PLC
04-30-15 UCB Reports Strong First-Quarter Sales; Share Remain Fully Valued Despite Modest FVE Increase UCB SA
04-30-15 Vertex’s 1Q Results as Expected; Orkambi Launch in CF is Key Focus for 2015 Vertex Pharmaceuticals Inc
04-27-15 Acrux's Axiron Sales Steady Despite Intensifying Generic Competition Acrux Ltd
1– 31 of 31   First 50   All (may be slower to load)

Corrections Site Map Help Advertising Opportunities Licensing Opportunities Glossary Store RSS feed
© Copyright 2015 Morningstar, Inc. All rights reserved. Please read our Terms of Use and Privacy Policy.
Content Partnersblack arrow
Popular Articles by: Title| Date| Author| Collection| Interest| Popularity
Popular Investment Categories by: Topic| Sector| Key Indicators| User Interest| Market Cap| Industry